EUVIMEDEUVIMED entdecken
Crossref

Response to Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”

Muhammad A Qudoos, David P Elliott

The Senior Care Pharmacist · 01.08.2026 · 41 (5) · 159-160

DOI: 10.4140/tcp.n.2026.159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Senior Care Pharmacist, erschienen am 01.08.2026. Verfasst von Muhammad A Qudoos und 1 weiteren Autor:innen. Beteiligte Einrichtung: 1Ambulatory Care Pharmacy, Samaritan Lebanon Community Hospital, Lebanon, OR.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • 1Ambulatory Care Pharmacy, Samaritan Lebanon Community Hospital, Lebanon, OR.
  • 2West Virginia University School of Pharmacy, Charleston, WV.

Zitieren

APA

Qudoos, M. A., & Elliott, D. P. (2026). Response to Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”. The Senior Care Pharmacist, 41(5), 159-160. https://doi.org/10.4140/tcp.n.2026.159

Vancouver

Qudoos MA, Elliott DP. Response to Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”. The Senior Care Pharmacist. 2026;41(5):159-160. doi:10.4140/tcp.n.2026.159

BibTeX
@article{Qudoos2026,
  author = {Qudoos, Muhammad A and Elliott, David P},
  title = {Response to Comment on “Review of Donanemab and Lecanemab in Mild Dementia Stage of Alzheimer’s Disease: Progress and Challenges”},
  journal = {The Senior Care Pharmacist},
  year = {2026},
  volume = {41},
  number = {5},
  pages = {159--160},
  doi = {10.4140/tcp.n.2026.159}
}
Kostenlos starten →